Innovus Pharmaceuticals Inc (INNV) 0.4750

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Innovus Pharmaceuticals Inc (INNV) 0.4750 $INNV

SECFilings.com: Innovus Pharma (INNV) Reaches a Positive Cash Flow & Issues Strong Outlook
Marketwired - Thu Aug 18, 5:00AM CDT
Independent Analyst Suggests Price Target 170% Higher Than Current Levels Based on Strong Future Growth and Profitability

SeeThruEquity Issues Update on Innovus Pharmaceuticals, Inc. (OTCQB: INNV) and Raises Price Target to $1.00
ACCESSWIRE - Mon Aug 15, 5:00AM CDT
NEW YORK, NY / ACCESSWIRE / August 15, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Innovus Pharmaceuticals, Inc. (OTCQB: INNV).

SECFilings.com: Innovus Pharma (INNV) Quarterly Revenue Soars Past $1M on 446% Growth With Positive Cash Flow
Marketwired - Thu Aug 11, 5:00AM CDT
REDONDO BEACH, CA--(Marketwired - Aug 11, 2016) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the release of an article covering Innovus Pharmaceuticals' (OTCQB: INNV) recent quarterly financial results and the numerous upcoming catalysts for the company's stock.

Innovus Pharma Turns Cash Flow Positive With Over $1 Million in Revenues for the Second Quarter 2016
Marketwire Canada - Tue Aug 09, 2:47PM CDT
Company Affirms Its Previously Announced Revenue Guidance of $5 Million for 2016

Innovus Pharmaceuticals to Host Its Second Quarter 2016 Financial Report Conference Call on August 9, 2016 at 4:15 p.m. EDT
Marketwire Canada - Fri Aug 05, 1:00PM CDT
SAN DIEGO, CA--(Marketwired - Aug 5, 2016) - Innovus Pharmaceuticals, Inc. ("Innovus Pharma" www.innovuspharma.com (OTCQB: INNV) announced today it will release its second quarter 2016 financial results before the open of trading on Tuesday, August 9, 2016 ahead of its 10-Q to be filed on August 15, 2016. The company will host a conference call at 4:15 p.m. EDT/1:15 p.m. PDT on the same day (August 9, 2016) to discuss the financial results and recent business developments.

Innovus Pharma Resumes Commercial Sale of Zestra With the Appointment of PT Laras Bumi Resources as Its Distributor for Select Asian Countries Including Japan, Korea, Indonesia and China
Marketwired - Thu Aug 04, 5:00AM CDT
PT Laras Bumi Resources Projects Close to 150,000 Units a Year

Innovus Pharmaceuticals Announces the Closing of Its $3M Private Financing From Institutional Investors
Marketwired - Mon Aug 01, 5:00AM CDT
Company in a Strong Cash Position for Product Launches and Expedited Growth

SECFilings.com Examines Innovus Pharmaceuticals' (INNV) Position in Multi-Billion Dollar Female Sexual Dysfunction Market
Marketwire Canada - Tue Jun 21, 8:01AM CDT
REDONDO BEACH, CA--(Marketwired - Jun 21, 2016) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, takes a look at the underserved Female Sexual Interest Arousal Dysfunction (FSI/AD) market and Innovus Pharmaceuticals' (OTCQB: INNV) clinically proven over-the-counter treatment, Zestra®.

Innovus Pharmaceuticals Announces Successful Top Line Results From RecalMax in Memory, Processing Speed and Thought Maintenance
Marketwired - Mon Jun 13, 5:00AM CDT
SAN DIEGO, CA--(Marketwired - Jun 13, 2016) - Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCQB: INNV), a company focusing on the commercialization of over-the-counter ("OTC" and consumer products for men's and women's health, vitality and respiratory diseases, announced today that the Company's top line results from its RecalMax™ U.S. four month human survey use clinical trial in people with low memory and learning.

Innovus Pharma (INNV)'s Vesele Could Be the Best Complementary Product for Viagra and Cialis's $3.2 Billion Dollar Erectile Dysfunction Market
Marketwire Canada - Thu Jun 09, 5:00AM CDT
SAN DIEGO, CA--(Marketwired - Jun 9, 2016) -  Innovus Pharma (OTCQB: INNV) -- The global erectile dysfunction drug market is expected to reach $3.2 billion USD by 2022 according to a new report by Grand View Research Inc. Male sexual dysfunction has become a multi-billion-dollar market fueled by sales of erectile dysfunction drugs like Viagra and Cialis. In fact, Pfizer Inc.'s Viagra surpassed $1 billion in sales during its first year despite having lower than usual third-party coverage. The drug has consistently surpassed $1 billion per year in sales since its launch and even briefly reached above the $2 billion mark back in 2012 despite growing competition.
PFE: 34.98 (-0.21)

Innovus Pharma Announces the Filing of the Product Licenses for Zestra, Zestra Glide, EjectDelay and Sensum+ With the Indian FDA (Directorate General of Health Services) by Its Partner Khandelwal Laboratories
Marketwire Canada - Tue Jun 07, 5:00AM CDT
SAN DIEGO, CA--(Marketwired - Jun 7, 2016) - Innovus Pharmaceuticals, Inc. ("Innovus Pharma" (OTCQB: INNV), an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women's health and respiratory diseases, today announced today that its partner Khandelwal Laboratories filed the product licenses for Zestra®, Zestra Glide®, EjectDelay® and Sensum+® with the Indian FDA, The Drugs Controller General (India) and the Directorate General of Health Services to commercialize the products in India.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing K-12 Education: Five Star's Virtual Help Desk

Updated Category News Views 159

Five Star Technology Solutions' Anniversary Celebration Five Star Technology Solutions proudly commemorates three years since the launch of its innovative Virtual Help Desk (vHD), a service dedicated to enhancing K–12 education. This powerful tool has redefined how schools and districts obtain technical support, resulting in increased efficiency and cost savings, while...

Continue Reading
Exploring the Dynamics of Small-Cap Investments in RVT

Updated Category News Views 181

Understanding Royce Small-Cap Trust Royce Small-Cap Trust (NYSE: RVT) stands as the oldest and largest closed-end fund dedicated to small-cap stocks. By focusing on these smaller companies, the trust has carved out a unique niche in the investment landscape. Key Highlights The fund enjoys an impressive weekly trading volume of around 974,286 shares, reflecting strong...

Continue Reading
Projected Growth of Peripheral Intravenous Catheters Market

Updated Category News Views 215

Overview of the Peripheral Intravenous Catheters Market The peripheral intravenous catheters (PIVCs) market is on track to reach a striking valuation of USD 10.9 billion by 2032. This expected growth is primarily propelled by the rising number of both elective and emergency surgeries conducted around the world. Increasing Need for Intravenous Access Every year, over 310...

Continue Reading
Vaxart Announces New Lead Independent Director Appointment

Updated Category News Views 122

Appointment of W. Mark Watson SOUTH SAN FRANCISCO, Calif. — Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company, proudly announces the appointment of W. Mark Watson as its Lead Independent Director. With a wealth of knowledge spanning over 50 years in the field of accounting and business, Mr. Watson is set to significantly enhance the strategic direction...

Continue Reading
Legal Review of Potential Securities Fraud by Stellantis N.V.

Updated Category News Views 176

Understanding the Investigation into Stellantis N.V. There is an ongoing investigation regarding potential securities fraud claims against Stellantis N.V. (NYSE: STLA). This inquiry arises due to allegations that the company may have made inaccurate statements about its business performance and future prospects. The focus of the investigation highlights key elements of...

Continue Reading